Reda G. Yousef

Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects

Eslam B. Elkaeed, Reda G. Yousef, Hazem Elkady et al. · Molecules · 2022 · 113 citations · Full text

Discovery of new quinoxaline-2(1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation

Khaled El‐Adl, Helmy Sakr, Reda G. Yousef et al. · Bioorganic Chemistry · 2021 · 105 citations

Medicinal Chemistry, Drug Targeting, Medicine +7

New quinoxaline-2(1<i>H</i>)-ones as potential VEGFR-2 inhibitors: design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations

Reda G. Yousef, Helmy Sakr, Ibrahim H. Eissa et al. · New Journal of Chemistry · 2021 · 78 citations

Molecular Docking, Molecular Pharmacology, Medicinal Chemistry +15

Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies

Reda G. Yousef, Albaraa Ibrahim, Mohamed M. Khalifa et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2022 · 52 citations · Full text

The Assessment of Anticancer and VEGFR-2 Inhibitory Activities of a New 1H-Indole Derivative: In Silico and In Vitro Approaches

Eslam B. Elkaeed, Reda G. Yousef, Hazem Elkady et al. · Processes · 2022 · 52 citations · Full text

Chemoprevention Strategy, New 1H-indole Derivative, Peptide Science +24